| 000 | 01683nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025948.0 | ||
| 008 | 091110s2009 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.07.M.Sc.2009.Ma.H | ||
| 100 | 0 | _aMai Hamed Mohamed Kamel | |
| 245 | 1 | 0 |
_aHuman epidermal growth factor receptor HER-2/neu oncoprotein in breast cancer / _cMai Hamed Mohammed Kamel ; Supervised Fatma Ahmed Fathi Elmougy , Marianne Samir Makboul , Ahmed Mostafa Ahmed Mahmoud |
| 246 | 1 | 5 | _aالبروتين السرطانى المستقبل لعامل نمو البشرة الآدمية فى سرطان الثدى |
| 260 |
_aCairo : _bMai Hamed Mohamed Kamel , _c2009 |
||
| 300 |
_a114 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology | ||
| 520 | _aBreast cancer | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aBreast cancer is the most common malignancy in women human epidermal growth factor receptoe ( HER-2/neu ) is an important prognostic indicator in breast cancer this study was performed on 49 breast cancer patients 16 benign breast lesions and 15 age matched normal controls | |
| 653 | 4 | _aHER-2/neu | |
| 653 | 4 | _aImmunochemiluminescence | |
| 700 | 0 |
_aAhmed Mostafa Ahmed Mahmoud , _eSupervisor |
|
| 700 | 0 |
_aFatma Ahmed Fathi Elmougy , _eSupervisor |
|
| 700 | 0 |
_aMarianne Samir Makboul , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aEnas _eCataloger |
||
| 905 |
_aMustafa _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c24454 _d24454 |
||